Company Filing History:
Years Active: 2019
Title: Lisa Bamber: Innovator in GITRL Fusion Proteins
Introduction
Lisa Bamber is a prominent inventor based in Cambridge, GB. She has made significant contributions to the field of biotechnology, particularly in the development of GITRL fusion proteins. Her work focuses on innovative solutions for cancer treatment, showcasing her dedication to advancing medical science.
Latest Patents
Lisa Bamber holds a patent for "GITRL fusion proteins comprising a human coronin 1a derived trimerization domain." This patent describes GITRL fusion polypeptide subunits that include an IgG Fc domain, a trimerization domain, and the receptor binding domain of GITR ligand. The fusion polypeptide subunits are capable of self-assembling into hexameric proteins. Additionally, the patent outlines methods for creating these fusion polypeptide subunits and hexameric proteins, as well as their applications in cancer treatment.
Career Highlights
Throughout her career, Lisa has demonstrated a strong commitment to research and innovation. She is currently associated with Medimmune Limited, where she continues to explore new avenues in biotechnology. Her work has the potential to impact the treatment of cancer significantly.
Collaborations
Lisa collaborates with talented individuals such as Ross Anthony Stewart and Natalie Jo Tigue. These partnerships enhance her research efforts and contribute to the advancement of her projects.
Conclusion
Lisa Bamber is a remarkable inventor whose work in GITRL fusion proteins exemplifies her commitment to improving cancer treatment. Her innovative approach and collaboration with other experts in the field position her as a key figure in biotechnology.